| Bioactivity | PXL770 is a direct AMP kinase activator. PXL770 can be used in the research of non-alcoholic fatty liver disease (NAFLD)[1]. |
| Name | PXL770 |
| CAS | 1523493-53-9 |
| Formula | C23H18ClNO3S |
| Molar Mass | 423.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kenneth Cusi, et al. Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Gastroenterol Hepatol. 2021, 6, 11. |
PXL770
CAS: 1523493-53-9 F: C23H18ClNO3S W: 423.91
PXL770 is a direct AMP kinase activator. PXL770 can be used in the research of non-alcoholic fatty liver disease (NAFLD)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.